Page 49 - Read Online

Page 2 of 2 Cheung et al. J Cancer Metastasis Treat 2019;5:60 I http://dx.doi.org/10.20517/2394-4722.2018.74

DECLARATIONS
Authors’ contributions
Manuscript drafting: Cheung CHA.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Thorburn A. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 2008;13:1-9.
2. Brech A, Ahlquist T, Lothe RA, Stenmark H. Autophagy in tumour suppression and promotion. Mol Oncol 2009;3:366-75.
3. Prieto-Domínguez N, Ordóñez R, Fernández A, García-Palomo A, Muntané J, et al. Modulation of Autophagy by Sorafenib: Effects on
Treatment Response. Front Pharmacol 2016;7:151.
4. Duffy A, Le J, Sausville E, Emadi A. Autophagy modulation: a target for cancer treatment development. Cancer Chemother Pharmacol
2015;75:439-47.
5. Janji B, Berchem G, Chouaib S. Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating
Tumor Immunity. Front Immunol 2018;9:887.
6. Lee JYC, Kuo CW, Tsai SL, Cheng SM, Chen SH, et al. Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an
Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells. Front Pharmacol 2016;7:81.
7. Kaliszczak M, van Hechanova E, Li Y, Alsadah H, Parzych K, et al. The HDAC6 inhibitor C1A modulates autophagy substrates in diverse
cancer cells and induces cell death. Br J Cancer 2018;119:1278-87.